Suzy Benedict
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Suzy Benedict
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Suzy Benedict
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| FRANKLIN RESOURCES, INC. | Investment Managers | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Franklin Templeton Investments Corp.
 Franklin Templeton Investments Corp. Investment ManagersFinance Franklin Templeton Investments Corp. (FTIC) is a SEC-registered investment advisor and mutual fund manager headquartered in Toronto, Canada. The firm was founded in 2000 and is a wholly-owned subsidiary of Templeton International, Inc., ultimately owned by Franklin Resources, Inc. (NYSE: BEN). FTIC provides investment advisory and portfolio management services with clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as separate accounts for institutional and high net-worth clients. | Investment Managers | Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
ImVision Therapeutics, Inc.
 ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImVision Therapeutics, Inc. develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. The company was founded on January 28, 2005 and is headquartered in Hanover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member | |
PMG Investment Solutions AG
 PMG Investment Solutions AG Investment ManagersFinance Part of Swiss Pension & Investment Group AG, PMG Investment Solutions AG is an independent Swiss fund management company based in Zurich, Switzerland. With almost 20 years of experience, PMG provides a range of fund management services, including administration and individualized solutions for funds in Switzerland and abroad. The company was founded in 1992, and the CEO is Bernhard Schneider. | Investment Managers | Portfolio Manager-Equities | |
| JAFCO GROUP CO., LTD. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Chief Executive Officer Chief Investment Officer | |
| Emory University | College/University | Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| DOTTIKON ES HOLDING AG | Chemicals: Specialty | Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Chief Administrative Officer | |
| Friedrich Miescher Institute | College/University | Doctorate Degree | |
| Kyoto University | College/University | Graduate Degree | |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Chairman | |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cadence, Inc.
 Cadence, Inc. Medical SpecialtiesHealth Technology Cadence, Inc. manufactures and designs cutting and piercing instruments. Its products include advanced surgical, custom OEM products, specialty blades-custom, specialty blades catalog, and cadence science catalog. The company was founded by Martin F. Lightsey in 1985 and is headquartered in Staunton, VA. | Medical Specialties | Corporate Secretary | |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| Nextech III GP AG | Director/Board Member | ||
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| Nextech Holding AG | Chairman | ||
| ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Dottikon Es Management AG | Director/Board Member | ||
Medimaps Group SA
 Medimaps Group SA Packaged SoftwareTechnology Services Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland. | Packaged Software | Director/Board Member | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Director/Board Member | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Swiss Scientific Computing Center
 Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Nextech Venture Principals Ltd.
 Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey. | Financial Conglomerates | Director/Board Member | |
| Rising Tide Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| NLS PHARMACEUTICS AG | Pharmaceuticals: Major | Director/Board Member | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Julier Partners GmbH | Founder | ||
| 8stogg AG | Director/Board Member | ||
| Wemedoo AG | Chairman |
Statistik
International
| Vereinigte Staaten | 26 |
| Schweiz | 20 |
| Kanada | 3 |
| Deutschland | 3 |
| Japan | 3 |
Sektoral
| Health Technology | 22 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 98 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 26 |
| Undergraduate Degree | 17 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ted Wang | 20 |
| Alfred Scheidegger | 20 |
| William T. Comer | 15 |
| Rainer Twiford | 15 |
| William LaRue | 15 |
| Mark Wiggins | 15 |
| Saundra Pelletier | 13 |
| Hironori Hozoji | 13 |
| Stephen Worland | 12 |
| James L. Freddo | 11 |
| Martin Mattingly | 10 |
| Myoung-Ok Kwon | 10 |
| Ronald Shazer | 9 |
| Paul Walker | 9 |
| Casey Logan | 8 |
- Börse
- Insiders
- Suzy Benedict
- Unternehmensverbindungen
